Suchergebnisse - "Ma, Fei"

PubPharm (8)

1

Predictive value of topoisomerase II alpha protein for clinicopathological characteristics and prognosis in early breast cancer

enthalten in: Breast cancer research and treatment | 2022

von Wu, Y. | Han, Y. | Li, Q. | +12

2

Predictive value of topoisomerase II alpha protein for clinicopathological characteristics and prognosis in early breast cancer

enthalten in: Breast cancer research and treatment | 2022

von Wu, Y. | Han, Y. | Li, Q. | +12

3

Predictive value of topoisomerase II alpha protein for clinicopathological characteristics and prognosis in early breast cancer

enthalten in: Breast cancer research and treatment | 2022

von Wu, Y. | Han, Y. | Li, Q. | +12

4

Predictive value of topoisomerase II alpha protein for clinicopathological characteristics and prognosis in early breast cancer

enthalten in: Breast cancer research and treatment | 2022

von Wu, Y. | Han, Y. | Li, Q. | +12

5

Primary Trastuzumab Resistance After (Neo)adjuvant Trastuzumab-containing Treatment for Patients With HER2-positive Breast Cancer in Real-world Practice

enthalten in: Clinical breast cancer | 2021

von Chen, X. | Wang, J. | Fan, Y. | +9

6

The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer

enthalten in: Cancer communications (London, England) | 2019

von Guan, X. | Ma, F. | Li, C. | +13

7

The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial–mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer

enthalten in: Cancer communications | 2019

von Guan, X. | Ma, F. | Li, C. | +13

8

The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial–mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer

enthalten in: Chinese journal of cancer | 2019

von Guan, X. | Ma, F. | Li, C. | +13

1
[1]